Immunogenicity and safety of CoronaVac vaccine in children and adolescents (Immunita-002, Brazil): A phase IV six-month follow up

Immunogenicity and safety of CoronaVac vaccine in children and adolescents (Immunita-002, Brazil): A phase IV six-month follow up

Abstract Vaccines are essential for the prevention and control of several diseases, and monitoring the immune response generated by vaccines is crucial. The immune response generated by vaccination against SARS-CoV-2 in children and adolescents is not well defined in terms of the intensity and mediu...

Full description

Saved in:
Bibliographic Details
Main Authors: Camila Amormino Corsini, Priscila Fernanda da Silva Martins, Priscilla Soares Filgueiras, Adelina Júnia Lourenço, Ana Esther de Souza Lima, Sarah Vieira Contin Gomes, Wander de Jesus Jeremias, Pedro Augusto Alves, Gabriel da Rocha Fernandes, Luciana Lisboa Mota e Castro, Andrea Teixeira-Carvalho, Ana Carolina Campi Azevedo, Caroline De Almeida Leitao Curimbaba, Daniela Aparecida Lorencini, Eolo Morandi Junior, Victor Mattos da Silva, Maria Célia Cervi, Marcos de Carvalho Borges, Maurício Lacerda Nogueira, Guilherme Rodrigues Fernandes Campos, Paulo Roberto Lopes Correa, Taciana Malheiros Lima Carvalho, Jordana Grazziela Alves Coelho dos Reis, Erik Vinícius de Sousa Reis, Leda dos Reis Castilho, Poliana Remundini de Lima, João Paulo Resende do Nascimento, Jaquelline Germano de Oliveira, Olindo Assis Martins Filho, Immunita Team, Rafaella Fortini Queiroz e Grenfell
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:Scientific Reports
Subjects:
Vaccine
CoronaVac
SARS-CoV-2
COVID-19
Neutralizing antibodies
Antibodies kinetics
Online Access:https://doi.org/10.1038/s41598-025-94596-9
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items